Inventor · disambiguated record
Song Mei
Also filed as: MEI SONG
41 granted patents·15 pending applications·559 citations·filing 2012–2025
98Inventor score
Top patents by PatentIndex Score
56 records- 0199US9181271B2Tricyclic fused thiophene derivatives as JAK inhibitorsINCYTE CORP·Filed 2013·Granted Nov 10, 2015·105 cites·6 claims
- 0298US11613536B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2021·Granted Mar 28, 2023·15 cites·15 claims
- 0398US10435392B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2018·Granted Oct 8, 2019·18 cites·28 claims
- 0498US10376513B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2018·Granted Aug 13, 2019·12 cites·21 claims
- 0598US9199982B2Heterocyclylamines as PI3K inhibitorsLI YUN-LONG·Filed 2012·Granted Dec 1, 2015·52 cites·15 claims
- 0697US11591318B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2021·Granted Feb 28, 2023·6 cites·19 claims
- 0797US11001571B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2019·Granted May 11, 2021·15 cites·16 claims
- 0897US10092570B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2017·Granted Oct 9, 2018·17 cites·20 claims
- 0997US9730939B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2015·Granted Aug 15, 2017·23 cites·7 claims
- 1097US9707233B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2015·Granted Jul 18, 2017·23 cites·21 claims
- 1197US9540347B2Pyridineamine compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Jan 10, 2017·19 cites·70 claims
- 1297US9382231B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2014·Granted Jul 5, 2016·40 cites·30 claims
- 1396US9926301B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2016·Granted Mar 27, 2018·18 cites·37 claims
- 1496US9580418B2Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2015·Granted Feb 28, 2017·19 cites·64 claims
- 1596US9126948B2Pyrimidine-4,6-diamine derivatives as PI3K inhibitorsCOMBS ANDREW P·Filed 2012·Granted Sep 8, 2015·27 cites·31 claims
- 1695US11905275B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2023·Granted Feb 20, 2024·2 cites·29 claims
- 1795US11780840B2Tricyclic urea compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2021·Granted Oct 10, 2023·4 cites·12 claims
- 1895US11433071B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2020·Granted Sep 6, 2022·3 cites·20 claims
- 1994US11819505B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2022·Granted Nov 21, 2023·1 cites·6 claims
- 2094US10646492B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2019·Granted May 12, 2020·9 cites·5 claims
- 2194US10053465B2Pyrrolopyrimidine derivatives as TAM inhibitorsINCYTE CORP·Filed 2016·Granted Aug 21, 2018·16 cites·37 claims
- 2294US9108984B2Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitorsCOMBS ANDREW P·Filed 2012·Granted Aug 18, 2015·32 cites·32 claims
- 2393US11136326B2Pyrrolopyrimidine derivatives as TAM inhibitorsINCYTE CORP·Filed 2019·Granted Oct 5, 2021·6 cites·31 claims
- 2493US9777017B2Tricyclic fused thiophene derivatives as JAK inhibitorsINCYTE CORP·Filed 2015·Granted Oct 3, 2017·9 cites·20 claims
- 2592US11767323B2Tricyclic pyridone compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2021·Granted Sep 26, 2023·3 cites·37 claims
- 2692US10370387B2Tricyclic fused thiophene derivatives as JAK inhibitorsINCYTE CORP·Filed 2018·Granted Aug 6, 2019·6 cites·15 claims
- 2792US10000507B2Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Jun 19, 2018·12 cites·18 claims
- 2892US9908895B2Tricyclic fused thiophene derivatives as JAK inhibitorsINCYTE CORP·Filed 2015·Granted Mar 6, 2018·8 cites·2 claims
- 2991US11851442B2Tricyclic fused thiophene derivatives as JAK inhibitorsINCYTE CORP·Filed 2021·Granted Dec 26, 2023·1 cites·12 claims
- 3091US9556197B2Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2014·Granted Jan 31, 2017·19 cites·48 claims
- 3191US2025325550A1Heterocyclylamines as pi3k inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 3289US12201636B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2023·Granted Jan 21, 2025·0 cites·8 claims
- 3389US9932341B2Use of pyrazolopyrimidine derivatives for the treatment of PI3K-delta related disordersINCYTE CORP·Filed 2014·Granted Apr 3, 2018·9 cites·50 claims
- 3488US2024228508A1Tricyclic fused thiophene derivatives as jak inhibitorsINCYTE CORP·Filed 2023·Application pending·0 cites
- 3587US12247020B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2024·Granted Mar 11, 2025·0 cites·20 claims
- 3686US11161855B2Tricyclic fused thiophene derivatives as JAK inhibitorsINCYTE CORP·Filed 2019·Granted Nov 2, 2021·3 cites·54 claims
- 3786US10519163B2Pyrrolopyrimidine derivatives as TAM inhibitorsINCYTE CORP·Filed 2018·Granted Dec 31, 2019·4 cites·38 claims
- 3886US2025289823A1Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disordersINCYTE CORP·Filed 2024·Application pending·0 cites
- 3983US11459329B2Imidazopyridazine and imidazopyridine compounds and uses thereofINCYTE CORP·Filed 2019·Granted Oct 4, 2022·3 cites·61 claims
- 4082US12415809B2Pyrrolotriazine compounds as tam inhibitorsINCYTE CORP·Filed 2023·Granted Sep 16, 2025·0 cites·33 claims
- 4181US2025320212A1Tricyclic urea compounds as jak2 v617f inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 4280US2025206726A1Bipyrazole derivatives as jak inhibitorsINCYTE CORP·Filed 2025·Application pending·0 cites
- 4378US12030889B2Imidazopyridazine and imidazopyridine compounds and uses thereofINCYTE CORP·Filed 2022·Granted Jul 9, 2024·0 cites·12 claims
- 4477US12152033B2Use of pyrazolopyrimidine derivatives for the treatment of PI3K-δ related disordersINCYTE CORP·Filed 2021·Granted Nov 26, 2024·0 cites·6 claims
- 4577US2024309008A1Imidazopyridazine and imidazopyridine compounds and uses thereofINCYTE CORP·Filed 2024·Application pending·0 cites
- 4676US2025325660A1Immunomodulator compounds and methods of useINCYTE CORP·Filed 2025·Application pending·0 cites
- 4764US2020397893A1Immunomodulator compounds and methods of useINCYTE CORP·Filed 2020·Application pending·0 cites
- 4864US2020172533A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Application pending·0 cites
- 4960US2019040067A1Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disordersINCYTE CORP·Filed 2018·Application pending·0 cites
- 5060US2018057486A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2017·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Song Mei files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →